Post-Transplant Clinic Follow-Up Note

Date: [date of visit]

Patient: [patient name and identifier]

Provider: [clinician name and role]

Transplant: [organ type], [transplant date], [post-transplant interval]

Visit Type: [routine surveillance / problem-focused: specify concern]

Chief Concern

[reason for visit or clinician-defined focus] (Include a brief direct quote only if it meaningfully clarifies symptoms or adherence issues.)

Interval History

[narrative since last visit covering: time since prior visit; interval events such as hospitalizations, procedures, infections, or rejection episodes; graft-function symptoms; immunosuppression adherence and tolerability; infection-related symptoms; medication changes and by whom; key labs or trends already known] (Write as one concise paragraph. For stable patients, explicitly document stability with brief supporting context.)

Transplant Summary

(Update only when new events occur.)

Indication: [original transplant indication]

Donor: [living / deceased], [CMV D/R status], [other relevant donor factors]

Immunosuppression: [current maintenance regimen]

Rejection history: [dates, type/grade, and treatment / none]

Baseline graft function: [organ-appropriate baseline markers]

Objective

Vitals: [BP, HR, weight with change from prior, temperature, SpO2] (Note clinically significant changes.)

Exam: [pertinent findings: general appearance, volume status, cardiopulmonary, abdomen/graft site, incisions/lines/drains, skin] (Document targeted normals rather than full templates.)

Data: [key labs with dates; immunosuppressant levels with timing context noting if true trough; viral monitoring with dates; imaging/procedures with brief impressions] (Use trend format for graft-defining labs when helpful.)

Assessment & Plan

(Problem-oriented, numbered by severity. For each problem include assessment with supporting evidence, plan with specific actions, and monitoring with timelines. Never state "stable" without citing objective data. For immunosuppression changes, document reason, new dose, start date, and monitoring plan. Prophylaxis stop dates must be explicit.)

1. Graft function: [stable / improving / worsening]

   [assessment with supporting objective data; differential if abnormal; diagnostic and therapeutic plan; monitoring timeline and thresholds]

2. Immunosuppression: [current regimen with most recent levels and timing context]

   [adequacy relative to targets; toxicity considerations; changes today with rationale, new dose, and monitoring plan; level interpretation]

3. Infection prophylaxis: [current agents]

   [status and risk considerations; agents with explicit stop dates or criteria; surveillance assays and schedule; vaccination actions if relevant]

4. [other active problem]:

   [assessment with supporting data; plan with specific actions; monitoring parameters and thresholds]

Follow-up

• [next labs and timing]
• [next appointment timing and modality]
• [return precautions: fever threshold, graft-specific warning signs]
• [result review and patient communication plan]